Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Aileron Therapeutics Inc (ALRN) is now available.
Aileron Therapeutics, Inc. has appointed Timothy M. Cunningham as the interim chief financial officer starting May 16, 2024, following the departure of the former CFO, Charles Garner. Cunningham, with extensive experience in financial leadership roles and a background as a consultant at Danforth Advisors, will now oversee the company’s financial and accounting operations. His appointment comes under a consulting agreement where his expertise in guiding public and private life sciences companies will be an asset to Aileron Therapeutics.
See more insights into ALRN stock on TipRanks’ Stock Analysis page.